{"id":179631,"date":"2024-01-01T17:23:00","date_gmt":"2024-01-01T23:23:00","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/01\/research-at-msk-unlocks-new-potentials-in-cancer-treatment"},"modified":"2024-01-01T17:23:00","modified_gmt":"2024-01-01T23:23:00","slug":"research-at-msk-unlocks-new-potentials-in-cancer-treatment","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/01\/research-at-msk-unlocks-new-potentials-in-cancer-treatment","title":{"rendered":"Research at MSK unlocks new potentials in cancer treatment"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/research-at-msk-unlocks-new-potentials-in-cancer-treatment2.jpg\"><\/a><\/p>\n<p>Memorial Sloan Kettering Cancer Center (MSK) has spearheaded revolutionary research unveiling groundbreaking strides in cancer treatment and understanding disease mechanisms.<\/p>\n<p>Their discoveries include<a href=\"https:\/\/www.mskcc.org\/news\/msk-research-highlights-december-29-2023?_subsite=research-ski\" title=\" CAR T cell therapy \" rel=\"dofollow\" target=\"_blank\" class=\"\"> CAR T cell therapy<\/a> targeting specific antigens in acute myeloid leukemia (AML), insights into the genetic element LINE-1, revelations on blood stem cell regulation, and a promising immunotherapy technique targeting CD47, showcasing potential breakthroughs in cancer therapy.<\/p>\n<p>In the battle against acute myeloid leukemia (AML), traditional CAR T cell therapies faced hurdles due to varying antigens in AML cells and their similarity to normal blood stem cells, risking broader immune system damage.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Memorial Sloan Kettering Cancer Center (MSK) has spearheaded revolutionary research unveiling groundbreaking strides in cancer treatment and understanding disease mechanisms. Their discoveries include CAR T cell therapy targeting specific antigens in acute myeloid leukemia (AML), insights into the genetic element LINE-1, revelations on blood stem cell regulation, and a promising immunotherapy technique targeting CD47, showcasing [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412],"tags":[],"class_list":["post-179631","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/179631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=179631"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/179631\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=179631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=179631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=179631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}